推荐产品
一般說明
SureWick® Pad Materials are designed and optimised for use in rapid diagnostic lateral flow tests that require superior consistency and performance. SureWick® cellulose fiber pad materials are used as sample and absorbant pads in lateral flow assays. This pack contains 100 sheets of 20cm x 30cm C083 cellulose fiber pad material.
應用
SureWick® Pad Materials are optimised for use as sample, conjugate, or absorbent pads in a broad range of Lateral Flow test applications, including Infectious Disease testing (COVID-19, HIV, Influenza, Malaria, STDs etc.), as well as in women’s health, biomarker detection, drugs of abuse testing, drug development, environmental testing, agricultural applications, food safety, product quality testing, and animal health.
特點和優勢
- SureWick® cellulose fiber pads are made from non-woven, 100% pure cellulose fiber.
- These pads do not contain binders or glues, which can interfere with assay performance.
- Manufactured to ensure excellent consistency, they provide reliable, predictable sample flow.
- They exhibit consistent thickness, bed volume, and uniform surface quality.
- Quick delivery and lead time.
- Backed by excellent technical support.
法律資訊
SUREWICK is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 1
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Analytical biochemistry, 588, 113471-113471 (2019-10-16)
An aptamer-based colorimetric lateral flow assay was developed for the detection of human epidermal growth factor receptor 2 (HER2). In this study, two approaches were examined using HER2 binding aptamers and gold nanoparticles. The first method used was a solution-based
Biosensors, 9(4) (2019-10-02)
An immunochromatographic test system has been developed for the simultaneous rapid multiplex serodiagnostics of bovine brucellosis, tuberculosis, and leukemia. The test system is based on the use of a conjugate of gold nanoparticles with the chimeric protein Cysteine-A/G and three
Diagnostics (Basel, Switzerland), 10(4) (2020-04-02)
Most of the current serological diagnosis of pertussis is based on pertussis toxin (PT) IgG antibodies and does not differentiate between vaccination and infection-induced antibodies. PT is included in all of acellular pertussis vaccines available in the world. Multiplex testing
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门